
handle: 11449/71706
Recurrent venous thromboembolism is a significant problem leading to increased morbidity and mortality. It has a high impact on patients' quality of life and imposes a great financial burden on society. Cumulative recurrence has been reported as 40% at 10 years, while the chance of developing postthrombotic signs and symptoms in the lower extremities almost quadruples when ipsilateral. There is also a higher chance of developing pulmonary hypertension. Important factors for recurrence are unprovoked episodes of deep vein thrombosis, malignancy and older age. The evidence for other factors is controversial. Accurate diagnosis and treatment tailored to the patients' history, thrombotic events and risk factors are necessary to optimize management and prevent recurrence.
survival rate, diagnostic imaging, recurrent disease, clinical classification, treatment indication, thrombosis prevention, 610, heparin, high risk patient, anticoagulant agent, deep vein thrombosis, Pulmonary hypertension, compression garment, computer assisted tomography, Anticoagulation, Postthrombotic syndrome, pulmonary hypertension, follow up, human, nuclear magnetic resonance imaging, postthrombosis syndrome, risk reduction, patient attitude, treatment duration, anticoagulant therapy, echography, risk assessment, medical history, mortality, quality of life, risk factor, sensitivity and specificity, symptomatology, antivitamin K, diagnostic accuracy, disease severity, disease duration, Recurrent venous thromboembolism, lung embolism, blood clot lysis
survival rate, diagnostic imaging, recurrent disease, clinical classification, treatment indication, thrombosis prevention, 610, heparin, high risk patient, anticoagulant agent, deep vein thrombosis, Pulmonary hypertension, compression garment, computer assisted tomography, Anticoagulation, Postthrombotic syndrome, pulmonary hypertension, follow up, human, nuclear magnetic resonance imaging, postthrombosis syndrome, risk reduction, patient attitude, treatment duration, anticoagulant therapy, echography, risk assessment, medical history, mortality, quality of life, risk factor, sensitivity and specificity, symptomatology, antivitamin K, diagnostic accuracy, disease severity, disease duration, Recurrent venous thromboembolism, lung embolism, blood clot lysis
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
